Hello Danielle,

I'm writing to introduce you to Cellibre, a deep tech company that has developed a biotech process to manufacture chemicals that serve critical roles in pharmaceuticals, health & wellness, clean beauty and industrial products. By using biology as a manufacturing technology, rather than petroleum and agriculture, they are creating more resilient chemical supply chains.
 
With chemical production viewed as a major national security issue, the DoD plans to invest $1 billion+ in domestic bioindustrial manufacturing infrastructure. Cellibre secured DoD funding to commercialize technologies for critical polymers and chemicals, boosting domestic supply and reducing dependence on foreign production. 
 
Their organism-agnostic platform scales across industries including energy and defense, and uses substantially less energy, water, and other natural resources. Strategic partnerships with cosmetics brands and contract manufacturers are driving rapid growth and impact.  
 
Please let me know if you're interested in learning more about the investment opportunity with Cellibre. I would be happy to request a deck for you to review and/or arrange a meeting with their management. 
 
Thank you for your consideration. 

Kind regards, 

Janet

Janet Kagan
Client Success Manager

FORCE Family Office

1460 Broadway
New York, NY  10036